Wall Street Journal Article

No Comments

What is Familial Hypercholesterolemia (FH)?
Wall Street Journal, June 20th, 2017

In a little box on the bottom of page A11 in the Health section of the Wall Street Journal yesterday, this important question finally appeared in the press.

The FH Foundation was happy to answer that question in depth … Read More



Advocating on Capitol Hill

No Comments

FH Advocates for Awareness headed to Capitol Hill to make sure their elected representatives #KnowFH.

The FH Foundation® trained a new group of FH Advocates June 3rd-4th in Washington D.C. After two days of intense preparation, these dedicated volunteers visited 24 Congressional offices on Capitol … Read More







Patients in need of cholesterol lowering therapy are not being granted access to it, according to a novel data analysis by the Familial Hypercholesterolemia Foundation. (PRNewsfoto/The FH Foundation)

FH Foundation’s FOCUS analysis shows that regardless of medical need, prescriptions for PCSK9 inhibitors are being rejected at high rates

1 Comment

Pasadena, Calif. – The Familial Hypercholesterolemia Foundation today published a study in Circulation revealing high rejection rates for PCSK9 inhibitors in the two at-risk patient populations approved for this novel cholesterol-lowering class of therapy.

The FH Foundation’s FOCUS (FH Optimal … Read More

1 2 3 9